A Case of Pancreas Squamous Cell Carcinoma with Partial Response to Treatment and Poor Prognosis

Message:
Article Type:
Case Report (بدون رتبه معتبر)
Abstract:
Introduction

Adenocarcinoma is the most common malignancy in pancreas. Normally there is no squamous cell in pancreas. Pancreas Squamous Cell Carcinoma (SCC) is a rare tumor and its presentation is like adenocarcinoma and no specific symptom and sign is reported. Tumor markers are not helpful for this disease.

Case presentation

We report a 55 year-old female patient who had pancreas SCC. All investigations were normal and no other site of SCC, as a possible source for metastasis, was found.  The tumor was not operable and she received 3 cycles of cisplatin and 5-fluorouracil. Then she received radiotherapy up to 44 Gy. Although she had partial response, operation was not again possible and then she received chemotherapy. Unfortunately she developed liver metastasis and passed away 9 months after diagnosis.

Conclusion

pancreas SCC is a rare tumor and the role of surgery and radiotherapy is not well studied. Chemotherapy is better to be administered according to SCC of other sites. Despite aggressive treatment, this malignant disease has a poor prognosis.

Language:
English
Published:
Canon Journal of Medicine, Volume:1 Issue: 3, Summer 2019
Pages:
84 to 90
magiran.com/p2595809  
دانلود و مطالعه متن این مقاله با یکی از روشهای زیر امکان پذیر است:
اشتراک شخصی
با عضویت و پرداخت آنلاین حق اشتراک یک‌ساله به مبلغ 1,390,000ريال می‌توانید 70 عنوان مطلب دانلود کنید!
اشتراک سازمانی
به کتابخانه دانشگاه یا محل کار خود پیشنهاد کنید تا اشتراک سازمانی این پایگاه را برای دسترسی نامحدود همه کاربران به متن مطالب تهیه نمایند!
توجه!
  • حق عضویت دریافتی صرف حمایت از نشریات عضو و نگهداری، تکمیل و توسعه مگیران می‌شود.
  • پرداخت حق اشتراک و دانلود مقالات اجازه بازنشر آن در سایر رسانه‌های چاپی و دیجیتال را به کاربر نمی‌دهد.
In order to view content subscription is required

Personal subscription
Subscribe magiran.com for 70 € euros via PayPal and download 70 articles during a year.
Organization subscription
Please contact us to subscribe your university or library for unlimited access!